Pais de Barros JP - Search Results

1

Activation of the constitutive androstane receptor decreases HDL in wild-type and human apoA-I transgenic mice.

Masson D, Qatanani M, Sberna AL, Xiao R, Pais de Barros JP, Grober J, Deckert V, Athias A, Gambert P, Lagrost L, Moore DD, Assem M. Masson D, et al. Among authors: pais de barros jp. J Lipid Res. 2008 Aug;49(8):1682-91. doi: 10.1194/jlr.M700374-JLR200. Epub 2008 Apr 27. J Lipid Res. 2008. PMID: 18441373 Free article.

2

Plasma ceramides are associated with MRI-based liver fat content but not with noninvasive scores of liver fibrosis in patients with type 2 diabetes.

Denimal D, Béland-Bonenfant S, Pais-de-Barros JP, Rouland A, Bouillet B, Duvillard L, Vergès B, Petit JM. Denimal D, et al. Among authors: pais de barros jp. Cardiovasc Diabetol. 2023 Nov 8;22(1):310. doi: 10.1186/s12933-023-02049-2. Cardiovasc Diabetol. 2023. PMID: 37940926 Free PMC article.

3

Resolved Psoriasis with Abundant Oleic Acid in Stratum Corneum Exhibits Lower T-Cell-Driven IL-17 Signature.

El Mahi Y, Varin A, Vetter M, Dal Zuffo L, Mazzeo L, Pais De Barros JP, Aubin F, Saas P, Gallais Sérézal I. El Mahi Y, et al. Among authors: pais de barros jp. J Invest Dermatol. 2023 Nov;143(11):2145-2152.e6. doi: 10.1016/j.jid.2023.04.021. Epub 2023 May 18. J Invest Dermatol. 2023. PMID: 37207807

4

Ceramide analog C2-cer induces a loss in insulin sensitivity in muscle cells through the salvage/recycling pathway.

Bandet CL, Tan-Chen S, Ali-Berrada S, Campana M, Poirier M, Blachnio-Zabielska A, Pais-de-Barros JP, Rouch C, Ferré P, Foufelle F, Le Stunff H, Hajduch E. Bandet CL, et al. Among authors: pais de barros jp. J Biol Chem. 2023 Jun;299(6):104815. doi: 10.1016/j.jbc.2023.104815. Epub 2023 May 11. J Biol Chem. 2023. PMID: 37178918 Free PMC article.

5

Apolipoprotein CI deficiency markedly augments plasma lipoprotein changes mediated by human cholesteryl ester transfer protein (CETP) in CETP transgenic/ApoCI-knocked out mice.

Gautier T, Masson D, Jong MC, Duverneuil L, Le Guern N, Deckert V, Pais de Barros JP, Dumont L, Bataille A, Zak Z, Jiang XC, Tall AR, Havekes LM, Lagrost L. Gautier T, et al. Among authors: pais de barros jp. J Biol Chem. 2002 Aug 30;277(35):31354-63. doi: 10.1074/jbc.M203151200. Epub 2002 Jun 17. J Biol Chem. 2002. PMID: 12070157 Free article.

6

Apolipoprotein CI overexpression is not a relevant strategy to block cholesteryl ester transfer protein (CETP) activity in CETP transgenic mice.

Gautier T, Masson D, Jong MC, Pais de Barros JP, Duverneuil L, Le Guern N, Deckert V, Dumont L, Bataille A, Zak Z, Jiang XC, Havekes LM, Lagrost L. Gautier T, et al. Among authors: pais de barros jp. Biochem J. 2005 Jan 1;385(Pt 1):189-95. doi: 10.1042/BJ20041149. Biochem J. 2005. PMID: 15339254 Free PMC article.

7

Effect of cholesteryl ester transfer protein (CETP) expression on diet-induced hyperlipidemias in transgenic rats.

Zak Z, Gautier T, Dumont L, Masson D, Deckert V, Duverneuil L, Pais De Barros JP, Le Guern N, Schneider M, Moulin P, Bataillard A, Lagrost L. Zak Z, et al. Among authors: pais de barros jp. Atherosclerosis. 2005 Feb;178(2):279-86. doi: 10.1016/j.atherosclerosis.2004.10.006. Atherosclerosis. 2005. PMID: 15694935

8

7-Ketocholesterol-induced apoptosis. Involvement of several pro-apoptotic but also anti-apoptotic calcium-dependent transduction pathways.

Berthier A, Lemaire-Ewing S, Prunet C, Montange T, Vejux A, Pais de Barros JP, Monier S, Gambert P, Lizard G, Néel D. Berthier A, et al. Among authors: pais de barros jp. FEBS J. 2005 Jun;272(12):3093-104. doi: 10.1111/j.1742-4658.2005.04723.x. FEBS J. 2005. PMID: 15955068 Free article.

9

Variable expressivity of the clinical and biochemical phenotype associated with the apolipoprotein E p.Leu149del mutation.

Faivre L, Saugier-Veber P, Pais de Barros JP, Verges B, Couret B, Lorcerie B, Thauvin C, Charbonnier F, Huet F, Gambert P, Frebourg T, Duvillard L. Faivre L, et al. Among authors: pais de barros jp. Eur J Hum Genet. 2005 Nov;13(11):1186-91. doi: 10.1038/sj.ejhg.5201480. Eur J Hum Genet. 2005. PMID: 16094309

10

Human apoA-I expression in CETP transgenic rats leads to lower levels of apoC-I in HDL and to magnification of CETP-mediated lipoprotein changes.

Masson D, Pais de Barros JP, Zak Z, Gautier T, Le Guern N, Assem M, Chisholm JW, Paterniti JR Jr, Lagrost L. Masson D, et al. Among authors: pais de barros jp. J Lipid Res. 2006 Feb;47(2):356-65. doi: 10.1194/jlr.M500288-JLR200. Epub 2005 Nov 10. J Lipid Res. 2006. PMID: 16282639 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

108 results

Search Page